WGS | GeneDx Holdings Corp. Stock Overview

(Stock Exchange: NASDAQ)

Day's Range	63.71 - 83.33
52 Week Range	16.65 - 117.75
Beta	2.40
Implied Volatility	121.66%
IV Rank	57.56%
Day's Volume	7,593,421
Average Volume	1,053,065
Shares Outstanding	28,531,600
Market Cap	1,907,337,460
Sector	Healthcare
Industry	Medical - Healthcare Information Services
IPO Date	2020-11-04

Valuation
Profitability
Growth
Health
P/E Ratio	-34.46
Forward P/E Ratio	N/A
EPS	-1.94
1YR Price Target	N/A
Dividend Yield	N/A
Dividend Per Share	N/A
Dividend ExDate	N/A
Dividend PayDate	N/A
Employees	1,000
Country	USA
Website	WGS

GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.

WGS's peers: NXGN, PRVA, AGTI, HSTM, CERT, MDRX, NRC, CPSI, DH, EUDA, ETAO, ACON, AKLI, HCTI, NHIQ, FOXO, BBLN, WGSWW

*Chart delayed

Analyzing fundamentals for WGS we got that it has weak fundamentals where Valuation is considered to be significantly overvalued, Profitability is unacceptably poor, Growth is very bad and Health is weak. For more detailed analysis please see WGS Fundamentals page.

Watching at WGS technicals we can see that long-term trend is bullish, while middle-term trend is bearish, as well as bearish short-term trend. More technicals details can be found on WGS Technicals page.